Showing 1 - 10 of 157
Lifelong immunoglobulin replacement is the standard, expensive therapy for severe primary antibody deficiencies. This treatment can be administrated either by intravenous immunoglobulin (IVIG) or subcutaneous infusions (SCIG) and delivered at home or in an out-patient setting. This study aims to...
Persistent link: https://www.econbiz.de/10011072699
Persistent link: https://www.econbiz.de/10010861406
Persistent link: https://www.econbiz.de/10010861586
Persistent link: https://www.econbiz.de/10010706996
Persistent link: https://www.econbiz.de/10010707914
This paper studies the relationship between the diffusion of innovative procedures for the treatment of heart attack and distributions of the cost and length of hospital stays. Using a sample of 5,681 stays observed in French public hospitals, we use microsimulation techniques to highlight...
Persistent link: https://www.econbiz.de/10010708126
Persistent link: https://www.econbiz.de/10010708384
Persistent link: https://www.econbiz.de/10010708719
The numbers of households in fuel poverty is increasing. Indeed, more and more people are struggling to heat their homes and therefore more and more people are exposed to low temperatures which can affect their health. In this paper, we use the French database of the Healthcare and Insurance...
Persistent link: https://www.econbiz.de/10011212047
This paper assesses the impact of a free means-tested complementary health insurance on doctor visits. In order to tackle the endogeneity issue of the complementary health insurance variable, we use information on the selection rule to qualify for the free plan and adopt a regression...
Persistent link: https://www.econbiz.de/10010764086